DUBLIN, March 7, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/lmh24f/payer_hotspots_in) has announced the addition of the "Payer Hotspots in Specialty & Oncology" report to their offering.
This Payer Hotspots survey focuses on the potential areas for increased management in specialty and oncology pharmaceuticals. The survey was conducted in the 3rd Quarter of 2015. Each of the 10 respondents hold a Medical Director position at a major health plan and cumulatively represent 41 million covered lives. All 10 MD's engaged completed the entire survey.
The life expectancy of some CF patients, due to new and innovative therapies, has been extended to over 40 years. This, in and of itself, is a good thing! The vast majority of CF patients will be diagnosed by age 12 - the approved age for beginning Orkambi treatment.
If 5,500 (two-thirds of population size) patients continue treatment for their chronic disease from age 12 to 41 (ages of approved treatment and average life expectancy, respectively), we can expect therapy to last 29 years on average. Orkambi could potentially cost someone a total of $41 billion to treat this population over their lifespan - $7.5 million per patient.
Questions Answered:
Companies Mentioned:
Report Structure:
Introduction
About this Survey
Areas of Focus
Current Percentage of Total Drug Spend: Specialty
Average Expected Percentage Growth of Total Drug Spend: Specialty
Percentage of Current Specialty Spend: By Indication
Two- to Three-Years Estimated Growth: Specialty
Targeted Categories for Increased Management: Specialty
Current Percentage of Total Drug Spend: Oncology
Expected Percentage Growth of Total Drug Spend: Oncology
Largest Categories & Estimated Percentage of Oncology Spending
Top Areas of Oncology Spending Growth over the Next 2-3 Years
Top 3 Therapy Classes of Expected Growth: Oncology
Top 3 Categories of Growth: Rare Diseases
Parting Thoughts
For more information visit http://www.researchandmarkets.com/research/lmh24f/payer_hotspots_in
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article